The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rates of peripheral neuropathy (PN) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM) treated with carfilzomib vs comparators in pivotal phase III trials.
 
Ruben Niesvizky
Consulting or Advisory Role - Celgene; Millennium; Onyx
Speakers' Bureau - Celgene; Millennium; Onyx
 
Vania Hungria
Consulting or Advisory Role - Janssen; Takeda
 
Joy Ho
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
Research Funding - Amgen; Novartis (Inst)
Travel, Accommodations, Expenses - Celgene
 
Aleksandr Suvorov
No Relationships to Disclose
 
Darrell White
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Takeda (Inst)
 
Dina Ben-Yehuda
No Relationships to Disclose
 
Lifen Zhou
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Karim S. Iskander
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Laura Rosinol
Honoraria - Celgene; Janssen